CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Michael Baumann

OPENALEX: A5004773599↗ORCID: 0000-0001-7758-1470↗

Affiliations

Organizations

National Institute on Drug Abuseauthorship · US National Institutes of Healthauthorship · US

Public evidence

3 connected articles

Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor.2023 · Europe PMC Repeated Exposure to the "Spice" Cannabinoid JWH-018 Induces Tolerance and Enhances Responsiveness to 5-HT<sub>1A</sub> Receptor Stimulation in Male Rats.2018 · Europe PMC Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ<sup>9</sup> -tetrahydrocannabinol.2017 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Michael Baumann - Medical Cannabis Research Engine